Comparison of signalling mechanisms involved in rat mesenteric microvessel contraction by noradrenaline and sphingosylphosphorylcholine

British Journal of Pharmacology

Volumn 138, Issue 1, 2003, Pages 261-271

  Altmann, Christoph ^a   Steenpaß, Veronika ^a   Czyborra, Peter ^a   Hein, Peter ^a   Michel, Martin C ^a,b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

1A adrenoceptor; Phospholipase C; Rho kinase; Sphingosylphosphorylcholine; Vasoconstriction

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 1,4 DIAMINO 2,3 DICYANO 1,4 BIS(METHYLTHIO)BUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 BUTANOL; 2 MORPHOLINO 8 PHENYLCHROMONE; 2 PIPERAZINYL 8 PHENYL 4H 1 BENZOPYRAN 4 ONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 4 AMINO 5 (4 CHLOROPHENYL) 7 TERT BUTYLPYRAZOLO[3,4]PYRIMIDINE; 4 AMINO 7 PHENYLPYRAZOLO[3,4]PYRIMIDINE; BUTANOL; CARBACHOL; DAIDZEIN; ENZYME INHIBITOR; FASUDIL; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LY 303511; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROPRANOLOL; PYRIMIDINE DERIVATIVE; RHO KINASE; SPHINGOSYLPHOSPHORYLCHOLINE; U 124; U 126; UNCLASSIFIED DRUG; UNINDEXED DRUG; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; MALE; MESENTERY BLOOD VESSEL; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICROCIRCULATION; NOREPINEPHRINE; PHOSPHORYLCHOLINE; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SPHINGOSINE; SPLANCHNIC CIRCULATION; VASOCONSTRICTION;

EID: 0037278832     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705028     Document Type: Article

References (44)

1. 2-adrenoceptor-mediated contractions of rabbit saphenous vein. Eur. J. Pharmacol., 277, 35-44.
2. ALLEN, B.G. & WALSH, M.P. (1994). The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem. Sci., 19, 362-368.
3. ANDERSON, R.A., BORONENKOV, I.V., DOUGHMAN, S.D, KUNZ, J. & LOIJENS, J.C. (1999). Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J. Biol. Chem., 274, 9907-9910.
4. BATCHELOR, T.J.P., SADABA, J.R., ISHOLA, A., PACAUD, P., MUNSCH, C.M. & BEECH, D.J. (2001). Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br. J. Pharmacol., 132, 302-308.
5. BATCHELOR, T.J.P., SADABA, J.R., ISHOLA, A., PACAUD, P., MUNSCH, C.M. & BEECH, D.J. (2001). Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery. Br. J. Pharmacol., 132, 302-308.
6. BISCHOFF, A., CZYBORRA, P., FETSCHER, C., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C., (2000a). Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br. J. Pharmacol., 130, 1871-1877.
7. BISCHOFF, A., CZYBORRA, P., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C. (2000b). Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br. J. Pharmacol., 130, 1878-1883.
8. BISCHOFF, A., FINGER, J. & MICHEL, M.C., (2001a). Nifedipine inhibits sphingosine-1-phosphate-induced renovacular contraction in vitro and in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol., 364, 179-182.
9. BISCHOFF, A., MEYER ZU HERINGDORF, D., JAKOBS, K.H. & MICHEL, M.C. (2001b). Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetised rats. Br. J. Pharmacol., 132, 1925-1933.
10. CHEN, H, BISCHOFF, A., SCHÄFERS, R.F., WAMBACH, G., PHILIPP, T. & MICHEL, M.C. (1997). Vasoconstriction of rat renal interlobar arteries by noradrenaline and neuropeptide Y. J. Auton. Pharmacol., 17, 137-146.
11. CHEN, H., FETSCHER, C., SCHÄFERS, R.F., WAMBACH, G., PHILIPP, T. & MICHEL, M.C. (1996). Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction. Naunyn-Schmiedeberg's Arch. Pharmacol., 353, 314-323.
12. CHUN, J., GOETZL, E.J., HLA, T., IGARASHI, Y., LYNCH, K.R., MOOLENAAR, W., PYNE, S., & TIGYI, G. (2002). International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev., 54, 265-269.
13. DAVIES, S.P., REDDY, H., CAIVANO, M. & COHEN, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J., 351, 95-105.
14. DESSY, C., KIM, I., SOUGNEZ, C.L., LAPORTE, R. & MORGAN, K.G. (1998). A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am. J. Physiol., 275, C1081-C1086.
15. DI SALVO, J., NELSON, S.R. & KAPLAN, N. (1997). Protein tyrosine phosphorylation in smooth muscle: a potential coupling mechanism between receptor activation and intracellular calcium. Proc. Soc. Exp. Biol. Med., 214, 285-301.
16. 1D-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, 649-662.
17. FETSCHER, C., CHEN, H., SCHÄFERS, R.F., WAMBACH, G., HEUSCH, G. & MICHEL, M.C. (2001). Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors. Naunyn-Schmiedeberg's Arch. Pharmacol., 363, 57-65.
18. FUKATA, Y., AMANO, M. & KAIBUCHI, K., (2001). Rho-rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol. Sci., 22, 32-39.
19. 1A-Adrenoceptors: subtypes, signaling, and roles in health and disease. Arch. Med. Res., 30, 449-458.
20. HINTON, J.M., ADAMS, D. & GARLAND, C.J. (1999). 5-Hydroxytryptamine stimulation of phospholipase D activity in the rabbit isolated mesenteric artery. Br. J. Pharmacol., 126, 1601-1608.
21. HOLLENBERG, M.D. (1994). Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol. Sci., 15, 108-114.
22. HONG, S.J. & CHANG, C.C. (1998). Novel inhibition of contractility by wortmannin in skeletal muscle. Br. J. Pharmacol., 124, 849-856.
23. 1 receptor-coupled signalling pathways. Naunyn-Schmiedeberg's Arch. Pharmacol., 362, 555-558.
24. IBITAYO, A.I., TSUNODA, Y., NOZU, F., OWYANG, C. & BITAR, K.N. (1998). Src kinase and PI-3-kinase as a transduction pathway in ceramide-induced contraction of colonic smooth muscle. Am. J. Physiol., 275, G705-G711.
25. JINSI, A., PARADISE, J. & DETH, R.C. (1996). A tyrosine kinase regulates α-adrenoceptor-stimulated contraction and phospholipase D activation in the rat aorta. Eur. J. Pharmacol., 302, 183-190.
26. LAGAUD, G.J.L., STOCLET, J.-C. & ANDRIANTSITOHAINA, R. (1996). Calcium handling and purinoceptor subtypes involved in ATP-induced contraction in rat small mesenteric arteries. J. Physiol. (London), 492, 689-703.
27. 2+ stores and the spontaneous electrical and contracile activity of the guinea-pig renal pelvis. Br. J. Pharmacol., 135, 1363-1374.
28. LOW, A.M., BOWDISH, D.M., PRASHAD, T.R. & GASPAR, V. (1994). Interactions of chloroethylclonidine with rauwolscine- and prazosin-sensitive adrenoceptors in dog saphenous vein. Br. J. Pharmacol., 113, 1263-1268.
29. MCFADZEAN, I. & GIBSON, A. (2002). The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br. J. Pharmacol., 135, 1-13.
30. MEYER, ZU HERINGDORF, D., HIMMEL, H.M. & JAKOBS, K.H. (2002). Sphingosylphosphorylcholine - biological functions and mechanisms of action. Biochim. Biophys. Acta, 1582, 178-189.
31. 2+ release and directly activates ion channels in mouse pancreatic acinar cells. Biochem. J., 324, 645-651.
32. MUKAI, Y., SHIMOKAWA, H., MATOBA, T., KANDABASHI, T., SATOH, S., HIROKI, J., KAIBUCHI, K. & TAKESHITA, A., (2001). Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. FASEB J., 10.1096/fj.00-0735fje.
33. MUTO, Y., NAGAO, T. & URUSHIDANI, T., (1997). The putative phospholipase C inhibitor U73122 and its negative control, U73343, elicit unexpected effects on the rabbit parietal cell. J. Pharmacol. Exp. Ther., 282, 1379-1388.
34. NEER, E.J. (1995). Heterotrimeric G proteins: organizers of transmembrane signals. Cell, 80, 249-257.
35. PYNE, S. & PYNE, N.J. (2000). Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J., 349, 395-402.
36. 2 adrenoceptor-mediated vasoconstriction in porcine palmar lateral vein. Br. J. Pharmacol., 133, 859-866.
37. 2+ sensitization in the bovine cerebral artery. Unimportant role for protein kinase C. Circ. Res., 91, 112-119.
38. SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236.
39. SPIEGEL, S. & MILSTIEN, S. (2000). Functions of a new family of sphingosine-1-phosphate receptors. Biochim. Biophys. Acta., 1484, 107-116.
40. SUGIYAMA, A., YATOMI, T., OZAKI, Y. & HASHIMOTO, K. (2000). Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc. Res., 46, 119-125.
41. 1A-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways. Naunyn-Schmiedeberg's Arch Pharmacol., 358, 100-110.
42. 2+ leels, myosin light chain phosphorylation and force in vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 120-127.
43. 2+-sensitization of vascular smooth muscle contraction: possible involvement of rho-kinase. FEBS Lett., 482, 85-90.
44. 1A-adrenoceptors mediating vasoconstriction to noradrenaline and nerve stimulation in the isolated perfused mesentery of rat. Br. J. Pharmacol., 114, 531-536.